Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.75 |
| ▸ | CES1 | P23141 | 4/20 | 0.75 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233056 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL10961549 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL8741844 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL17315852 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL3016254 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL284705 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337998 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL6817517 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL648617 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL174462 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225471-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | Hitachi Zosen Inova AG (CH) | 2023-08-16 | — | — | EP | claimed |
| WO-2022079004-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | HITACHI ZOSEN INOVA AG (CH) | 2022-04-21 | — | — | WO | claimed |
| US-5747537-A | Method of inhibiting parasitic activity | WASHINGTON UNIVERSITY (US) | 1998-05-05 | — | — | US | claimed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2024092274-A2 | ENDOCYTIC AGENTS | BIOVENTURES, LLC (US) | 2024-05-02 | — | — | WO | disclosed |
| EP-3422006-B1 | DETECTION OF RISK OF PRE-ECLAMPSIA | UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK (IE) | 2023-11-01 | — | — | EP | disclosed |
| EP-4225471-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | Hitachi Zosen Inova AG (CH) | 2023-08-16 | — | — | EP | disclosed |
| EP-4093730-A1 | HDAC DEGRADER | University of Leicester (GB) | 2022-11-30 | — | — | EP | disclosed |
| WO-2022079004-A1 | METHOD FOR CLEANING A GAS MIXTURE BY ADDING OZONE | HITACHI ZOSEN INOVA AG (CH) | 2022-04-21 | — | — | WO | disclosed |
| US-20210008917-A1 | THERMOSENSITIVE RECORDING MEDIUM, THERMOSENSITIVE RECORDING MEDIUM PRODUCING METHOD, AND ARTICLE | RICOH COMPANY, LTD. (JP) | 2021-01-14 | — | — | US | disclosed |
| EP-0492628-B1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | RICOH KK (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5521138-A | COLOR DEVELOPMENT AND CRYSTALLIZATION | RICOH COMPANY, LTD. (JP) | 1996-05-28 | — | — | US | disclosed |
| US-5500040-A | Ultraviolet-curable thermochromic ink composition | SAKURA COLOR PRODUCTS CORPORATION (JP) | 1996-03-19 | — | — | US | disclosed |
| US-5432534-A | Reversible thermosensitive coloring composition, recording medium, recording method, and image display apparatus using the recording medium | RICOH COMPANY, LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| US-5395433-A | Containing electron donor coloring and electron acceptor compounds which react to induce color formation; printers for computers, facsimile apparatus | RICOH COMPANY, LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| US-5296439-A | Support with reversible thermosensitive coloring recording layer containing electron donor coloring compound, electron acceptor which reacts to induce color formation | RICOH COMPANY, LTD. (JP) | 1994-03-22 | — | — | US | disclosed |
| EP-0576015-A1 | Method of reversible recording | Ricoh Company, Ltd (JP) | 1993-12-29 | — | — | EP | disclosed |
| EP-0492628-A1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | Ricoh Company, Ltd (JP) | 1992-07-01 | — | — | EP | disclosed |
| US-4124608-A | Preparation of 2-oxoalkanoic acids | TEXACO INC. (US) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | GPR119, INSR, IAPP | CES2 162/4885CES1 105/4885HAO1 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.